Dr. Ronald Scott Chamberlain, MD

Dr. Chamberlain practices at AdventHealth Connerton in Zephyrhills, Florida.

Dr. Chamberlain's NPI, 1063421766, was assigned on August 5, 2006. Dr. Chamberlain graduated from George Washington University School of Medicine and Health Sciences in 1991. Dr. Chamberlain holds Florida license ME148095.

Dr. Chamberlain's primary practice is AdventHealth Connerton, at 7050 Gall Blvd, Zephyrhills, FL 33541 in Pasco County. The practice phone is (866) 787-5822.

Dr. Chamberlain's primary practice is AdventHealth Connerton in Zephyrhills, Florida. The medical group on file is AristaMD. Dmand AI also links Dr. Chamberlain to 1 more group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Chamberlain practices. Vendor and product names are available with a free account.

Surgery is Dr. Chamberlain's primary specialty in the NPI Registry, under taxonomy code 208600000X. Dr. Chamberlain is board certified in surgery by the American Board of Surgery. Dmand AI has Dr. Chamberlain's licenses on file in 9 states: Florida, Georgia, Mississippi, Indiana, Arizona, New York, New Jersey, District of Columbia and Maryland.

Dmand AI lists appendectomy, esophagus, stomach, or upper small intestine surgery and gallbladder removal among the conditions Dr. Chamberlain treats.

CMS data shows 811 Medicare services from Dr. Chamberlain across 9 procedure codes in 2024, for 121 Medicare patients. Medicare paid $47,795 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 121 Medicare patients who saw Dr. Chamberlain in 2024. The largest group is 75 to 84, with 45 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 40% are also on Medicaid. Their average risk score is 4.12, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Chamberlain's median patient age at 8, with 33% women.

In 2022, Dr. Chamberlain wrote 15 Medicare Part D claims. They cover 1 drug, with $264 in total drug cost. In 2019, CMS named 19 claims across 1 drug.

Dmand AI links 150 papers to Dr. Chamberlain, published from 2008 to 2019. 2011 was the busiest year, with 16. The most frequent topics are Breast Neoplasms, Length of Stay and Pancreatic Neoplasms. Dr. Chamberlain has published most often in Am Surg. Dr. Chamberlain's most frequent co-authors are Umashankar K. Ballehaninna, MD, Krishnaraj Mahendraraj, MD and Nitin Babel, MD.

Dmand AI links Dr. Chamberlain to 2 clinical trials, 2 of them phase 3 studies. Conditions studied include Pain, Postoperative, Surgical Wound Infection and Postoperative Complications.

CMS Open Payments shows 75 general payments to Dr. Chamberlain from 17 drug and device companies from 2016 to 2021. Honoraria make up the largest share, 44% of the total. Lifecell Corporation paid the most, $11,281.

Dmand AI lists 8 awards for Dr. Chamberlain, most recently Inside Jersey Magazine Top Doctors in 2017.

Dr. Chamberlain graduated from George Washington University School of Medicine and Health Sciences in 1991. Dr. Chamberlain is a member of ACS, ASCO, SSAT, SAGES, SLS and SSO.

Dr. Chamberlain is in network with 17 carriers, including Elevance, Blue Cross Blue Shield of Michigan and Highmark. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.